The science behind lutein

Toxicology Letters

Volumn 150, Issue 1, 2004, Pages 57-83

  Alves Rodrigues, Alexandra ^a   Shao, Andrew ^b  

^a Kemin Industries Inc   (United States)

^b General Nutrition Corporation   (United States)

Author keywords

Age related macular degeneration; Bioavailability; Cataract; Chronic disease; Lutein; Supplementation; Toxicity

Indexed keywords

ANTIOXIDANT; CAROTENOID; ESTER DERIVATIVE; HIGH DENSITY LIPOPROTEIN; HYDROCARBON; INTESTINE ENZYME; LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; SCAVENGER; XANTHOPHYLL; ZEAXANTHIN;

ABSORPTION; BIOAVAILABILITY; BLOOD FLOW; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CATARACT; CLASSIFICATION; CLINICAL OBSERVATION; DIET SUPPLEMENTATION; DIETARY INTAKE; ENERGY; ESTERIFICATION; EVALUATION; EYE DISEASE; FILTER; FOOD COMPOSITION; FOOD SAFETY; HEALTH; HUMAN; LENS; LIGHT; MUTAGENICITY; NONHUMAN; NUTRIENT; POPULATION RESEARCH; PRIORITY JOURNAL; PURIFICATION; RADIATION INJURY; RETINA MACULA DEGENERATION; RETINA MACULA LUTEA; REVIEW; RISK REDUCTION; SCIENCE; SKIN DEFECT; SKIN PROTECTION; STEREOISOMERISM; STROKE; ULTRAVIOLET RADIATION; VISION; VISUAL ACUITY;

ANIMALIA;

EID: 1842531744     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2003.10.031     Document Type: Article

References (173)

1. Age-Related Eye Disease Study Research Group, A., 2001. A randomized, placebo-controlled, clinical trial of high-dose supplementation with Vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8. Arch. Ophthalmol. 119, 1417-1436.
2. Albanes D., Heinonen O.P., Taylor P.R., Virtamo J., Edwards B.K., Rautalahti M., Hartman A.M., Palmgren J., Freedman L.S., Haapakoski J., Barrett M.J., Pietinen P., Malila N., Tala E., Liippo K., Salomaa E.R., Tangrea J.A., Teppo L., Askin F.B., Taskinen E., Erozan Y., Greenwald P., Huttunen J. Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J. Natl. Cancer Inst. 88:1996;1560-1570.
3. Albanes D., Virtamo J., Taylor P.R., Rautalahti M., Pietinen P., Heinonen O.P. Effects of supplemental beta-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am. J. Clin. Nutr. 66:1997;336-372.
4. Alberg A. The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients. Toxicology. 180:2002;121-137.
5. Aleman T.S., Duncan J.L., Bieber M.L., de Castro E., Marks D., Gardner L.M., Steinberg J.D., Cideciyan A.V., Maguire M.G., Jacobson S.G. Macular pigment and lutein supplementation in retinitis pigmentosa and usher syndrome. Invest. Ophthalmol. Via Sci. 42:2001;1873-1881.
6. Algvere P.V., Seregard S. Age-related maculopathy: pathogenetic features and new treatment modalities. Acta Ophthalmol. Scand. 80:2002;136-143.
7. Alves-Rodrigues A., Thomas B. Fruit and vegetable intake and coronary heart disease. Ann. Intern. Med. 137:2002a;143-144. discussion.
8. Alves-Rodrigues A., Thomas B. The role of lutein in the prevention of atherosclerosis. J. Am. Coll. Cardiol. 40:2002b;835. discussion 835-836.
9. Ascherio A., Rimm E.B., Hernan M.A., Giovannucci E., Kawachi I., Stampfer M.J., Willeti W.C. Relation of consumption of Vitamin E, Vitamin C, and carotenoids to risk for stroke among men in the United States. Ann. Intern. Med. 130:1999;963-970.
10. Baroli I., Niyogi K. Molecular genetics of xanthophyll-dependent photoprotection in green algae and plants. Philos. Trans. R. Soc. Load B. Biol. Sci. 355:2000;1385-1394.
11. Beatty S., Boulton M., Henson D., Kob H.H., Murray I.J. Macular pigment and age related macular degeneration. Br. J. Ophthalmol. 83:1999;867-877.
12. Beatty S., Koh H., Phil M., Henson D., Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 45:2000;115-134.
13. Berendschot T.T., Goldbohm R.A., Klopping W.A., van de Kraats J., van Norel J., van Norren D. Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest. Ophthalmol. Via Sci. 41:2000;3322-3326.
14. Bernstein P.S., Yoshida M.D., Katz N.B., McClane R.W., Gellermann W. Raman detection of macular carotenoid pigments in intact human retina. Invest. Ophthalmol. Via Sci. 39:1998;2003-2011.
15. Bernstein P.S., Zhao D.Y., Wintch S.W., Ermakov I.V., McClane R.W., Gellermann W. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology. 109:2002;1780-1787.
16. Berson E.L. Nutrition and retinal degenerations. Int. Ophthalmol. Clin. 40:2000;93-111.
17. Bolton-Smith C., Woodward M., Tunstall-Pedoe H. The Scottish Heart Health Study. Dietary intake by fond frequency questionnaire and odds ratios for coronary heart disease risk I. Macronutrients. Eur. J. Clin. Nutr. 46:1992;75-84.
18. Bone R.A., Landrum J.T. Distribution of macular pigment components, zeaxanthin and lutein, in human retina. Methods Enzymol. 213:1992;360-366.
19. Bone R.A., Landrum J.T., Friedes L.M., Gomez C.M., Kilburn M.D., Menendez E., Vidial I., Wang W. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp. Eye Res. 64:1997;211-218.
20. Bone R.A., Landrum J.T., Guerra L.H., Ruiz C.A. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J. Nutr. 133:2003;992-998.
21. Bone R.A., Landrum J.T., Mayne S.T., Gomez C.M., Tibor S.E., Twaroska E.E. Macular pigment in donor eyes with and without AMD: A Case-Control Study. Invest. Ophthalmol. Via Sci. 42:2001;235-240.
22. Bone R.A., Landrum J.T., Tarsis S.L. Preliminary identification of the human macular pigment. Vision Res. 25:1985;1531-1535.
23. Bowen P.E., Herbat-Espinosa S.M., Hussain E.A., Stacewicz-Sapuntzakis M. Esterification does not impair lutein bioavalaibility in humans. J. Nutr. 132:2002;3668-3673.
24. Brady W.E., Mares-Perlman J.A., Bowen P., Stacewicz-Sapuntzakis M. Human serum carotenoid concentrations are related to physiologic and lifestyle factors. J. Nutr. 126:1996;129-137.
25. Breithaupt D.E., Bamedi A., Wirt U. Carotenol fatty acid esters: easy substrates for digestive enzymes? Comp. Biochem. Physiol. B: Biochem. Mol. Biol. 132:2002;721-728.
26. Britton G. Structure and properties of carotenoids in relation to function. FASEB J. 9:1995;1551-1558.
27. Broekmans W.M., Berendachot T.T., Klopping-Ketelaars I.A., de Vries A.J., Goldbohm R.A., Tijburg L.B., Kardinaal A.F., van Poppel G. Macular pigment density in relation to serum and adipose tissue concentrations of lutein and serum concentrations of zeaxanthin. Am. J. Clin. Nutr. 76:2002;595-603.
28. Bron A.L., Vrensen G.F., Koretz J., Maraini G., Harding J.J. The ageing lens. Ophthalmologica. 214:2000;86-104.
29. Brown L., Rimm E.B., Seddon J.M., Giovannucci E.L., Chasan-Taber L., Spiegelman D., Willett W.C., Hankinson S.E. A prospective study of carotenoid intake and risk of cataract extraction in US men. Am. J. Clin. Nutr. 70:1999;517-524.
30. Burdock G.A. The GRAS process. Food Technol. 57:2003;17.
31. Cai J., Nelson K.C., Wu M., Sternberg P., Jones D.P. Oxidative damage and protection of the RPE. Prog. Retin. Eye Res. 19:2000;205-221.
32. CANTOX Health Sciences International, 2003. Documentation Supporting the Generally Recognized As Safe (GRAS) Status of FloraGLO Crystalline Lutein for Use as a Food Ingredient. Mississauga, Ont., Canada.
33. Castenmiller J.J., West C.E., Linssen J.P., van het Hof K.H., Voragen A.G. The food matrix of spinach is a limiting factor in determining the bioavailability of beta carotene and to a lesser extent of lutein in humans. J. Nutr. 129:1999;349-355.
34. Chasan-Taber L., Willett W.C., Seddon J.M., Stampfer M.J., Rosner B., Colditz G.A., Speizer F.E., Hankinson S.E. A prospective study of carotenoid and Vitamin A intakes and risk of cataract extraction in US women. Am. J. Clin. Nutr. 70:1999;509-516.
35. Chen, J., Wu, A., Pathak, M.A., Rius-Diaz, F., Mihm, C.M., Goukassian, D., Gonzalez S., 2002. Dietary lutein and zeaxanthin partially prevent UVB-induced skin careinogenesia in the SKh-1 hairless mouse model (Abstract). In: Society for Investigative Dermatology. Los Angeles, CA.
36. Chow, C.K., 2000. Vitamin E. In: Stipanuk, M.H. (Ed.), Biochemical and Physiological Aspects of Human Nutrition. W.B. Saunders Company, Philedelphia, PA, pp. 584-596.
37. Christen W.G. Antioxidant vitamins and age-related eye disease. Proc. Assoc. Am. Physicians. 111:1999;16-21.
38. Collins A.R., Olmedilla B., Southon S., Granado F., Duthie S.J. Sarum carotenoids and oxidative DNA damage in human lymphocytes. Carcinogenesis. 19:1998;2159-2162.
39. Curran-Celentano J., Hammond B.R. Jr., Ciulla T.A., Cooper D.A., Pratt L.M., Danis R.B. Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am. J. Clin. Nutr. 74:2001;79-802.
40. Dagnelie G., Zorge I.S., McDonald T.M. Lutein improves visual function in some patients with retinal degeneration: a pilot study via the Internet. Optometry. 71:2000;147-164.
41. DeFreitas, Z., 2000. Prevelance of Lutein Vs. Lutein Eaters in Human Diets USDA-NNCC Carotenoid Database for U.S. Foods, 1998a. Kemin Foods, L.C., Des Moines, IA.
42. Demmig-Adams B., Gilmore A.M., Adams W.W. 3rd Carotenoids 3: in vivo function of carotenoids in higher plants. FASEB J. 10:1996;403-412.
43. Dreher F., Maibach H. Protective effects of topical antioxidants in humans. Curr. Probl. Dermatol. 29:2001;157-164.
44. Duncan I.L., Aleman T.S., Gardner L.M., De Castro E., Marks D., Emmons I.M., Bieber M.L., Steinberg I.D., Bennett I., Stone E.M., MacDonald I.M., Cideciyan A.V., Maguire M.G., Jacobson S.G. Macular pigment and lutein supplementation in choroideremia. Exp. Eye Res. 74:2002;371-381.
45. Dwyer J.H., Navab M., Dwyer K.M., Hassan K., Sun P., Shircore A., Hama-Levy S., Hough G., Wang X., Drake T., Merx C.N., Fogelman A.M. Oxygenated carotenoid lutein and progression of early atherosclerosis: The Los Angeles Atherosclerosis Study. Circulation. 103:2001;2922-2927.
46. ENVIRON International Corporation, 2001. Generally Recognized as Safe Determination for FloraGLO Crystalline Lutein. Arlington, VA.
47. Eye Disease Case-Control Study Group, E., 1993. Antioxidant status and neovascular age-related macular degeneration. Arch. Ophthalmol. 111, 104-109.
48. Faulhaber, D., 2001. Lutein inhibits UVB radiation-induced tissue swelling and suppression of the induction of contact hypersensitivity (CHS) in the mouse. In: Proceedings of the Investigative Dermatology Conference Washington, DC; J. Invest. Dermatol.
49. Fine S.L., Berger J.W., Maguire M.G., Ho A.C. Age-related macular degeneration. J. Med. 342:2000;483-492.
50. Ford E.S. Variations in serum carotenoid concentrations among United States adults by ethnicity and sex. Ethn. Dis. 10:2000;208-217.
51. Gale C.R., Hall N.F., Phillips D.I., Martyn C.N. Plasma antioxidant vitamins and carotenoids and age-related cataract. Ophthalmology. 108:2001;1992-1998.
52. Gey K.F. Prospects for the prevention of free radical disease, regarding cancer and cardiovascular disease. Br. Med. Bull. 49:1993;679-699.
53. Goldberg J., Flowerdew G., Smith E., Brody J.A., Tso M.O. Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am. J. Epidemiol. 128:1988;700-710.
54. Gonzalez de Mejia E., Loarca-Pina G., Ramos-Gomez M. Antimutagenicity of xanthophylls present in Aztec Marigold (Tagetes erecta) against 1-nitropyrene. Mutat. Res. 389:1997a;219-226.
55. Gonzalez de Mejia E., Ramos-Gomez M., Loarca-Pina G. Antimutagenic activity of natural xanthophylls against aflatoxin B1 in Salmonella typhimurium. Environ. Mol. Mutagen. 30:1997b;346-353.
56. Goralczcyk R., Barker F., Froescheis O., Aebiacher J.-C., Niggeman B., Kotte U., Schierle J., Pfannkuch F., Bausch J. Ocular safety of lutein and zeaxanthin in a long-term study in Cynomolgous monkeys. Assoc. Res. Vision Ophthalmol. 43:2002;2546.
57. Granado F., Olmedilla B., Gil-Martinez E., Blanco I. Lutein ester in serum after lutein supplementation in human subjects. Br. J. Nutr. 80:1998;445-449.
58. Ham W.T. Jr., Mueller H.A., Sliney D.H. Retinal sensitivity to damage from short wavelength light. Nature. 260:1976;153-155.
59. Handelman G.J., Dratz E.A., Reay C.C., van Kuijk I.G. Carotenoids in the human macula and whole retina. Invest. Ophthalmol. Via Sci. 29:1988;850-855.
60. Hankinson S.E., Stampfer M.J., Saddon J.M., Colditz G.A., Rosner B., Speizer F.E., Willett W.C. Nutrient intake and cataract extraction in women: a prospective study. BMJ. 305:1992;335-339.
61. Hennekens C.H., Buring I.E., Manson I.E., Stampfer M., Rosner B., Cook N.R., Belanger C., LaMotte F., Gaziano J.M., Ridker P.M., Willet W., Peto R. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N. Engl. J. Med. 334:1996;1145-1149.
62. Herbert V. Prooxidant effects of antioxidant vitamins. Introduction. J. Nutr. 126:1996;1197S-1200S.
63. Hirvonen T., Virtamo I., Korhonen P., Albanes D., Pietinen P. Intake of flavonoids, carotenoids, Vitamin C and E, and risk of stroke male smokers. Stroke. 31:2000;2301-2306.
64. Holick C.N., Michaud D.S., Stolzenberg-Solomon R., Mayne S.T., Pietinen P., Taylor P.R., Virtamo J., Albanes D. Dietary carotenoids, serum beta carotene, and retinol and risk of lung cancer in the alpha-tocopherol, beta-carotene cohort study. Am. J. Epidemiol. 156:2002;536-547.
65. Howard A.N., Williams N.R., Palmer C.R., Cambou J.P., Evans A.E., Foote J.W., Marques-Vidal P., McCrum E.E., Ruidavets J.B., Nigdikar S.V., Rajput-Williams J., Thurnham D.I. Do hydroxy-carotenoids prevent coronary heart disease? A comparison between Belfast and Toulouse. Int. J. Vitam. Nutr. Res. 66:1996;113-118.
66. Iribarren C., Folsom A., Jacobs D. Jr., Gross M.D., Belcher J.D., Eckfeldt J.H. Association of serum vitamin levels, LDL susceptibility to oxidation and autoantibodies against MDA-LDL with carotid atherosclerosis A case-control study. The ARIC Study Investigators. Atherosclerosis Risk in Communities. Arterioscler. Thromb. Vasc. Biol. 17:1997;1171-1177.
67. Ito Y., Gajalakshmi K.C., Sasaki R., Suzuki K., Shanta V. A study on serum carotenoid levels in breast cancer patients of Indian women in Chennai (Madras). India J. Epidemiol. 9:1999;306-314.
68. Jacques P.F. The potential preventive effects of vitamins for cataract and age-related macular degeneration. Int. J. Vitam. Nutr. Res. 69:1999;198-205.
69. Jacques P.F., Chylack L.T. Jr., Hankinson S.E., Khu P.M., Rogers G., Friend J., Tung W., Wolfe J.K., Padhye N., Willen W.C., Taylor A. Long-term nutrient intake and early age-related nuclear lens opacities. Arch. Ophthalmol. 119:2001;1009-1019.
70. Jenkins M.Y., Mitchell G.V., Grundel E. Natural tocopherols in a dietary supplement of lutein affect tissue distribution of tocopherols in young rats. Nutr. Cancer. 37:2000;207-214.
71. Johnson E.J. The role of carotenoida in human health. Nutr. Clin. Care. 5:2002;56-65.
72. Johnson E.J., Hammond B.R., Yeum K.J., Qin J., Wang X.D., Castaneda C., Snodderly D.M., Rusell R.M. Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am. J. Clin. Nutr. 71:2000;1555-1562.
73. Jost J.P., Simon C., Nuttens M.C., Bingham A., Ruidavets J.B., Camhou J.P., Arveiler D., Lecerf J.M., Schlienger J.L., Douste-Blazy P. Comparison of dietary patterns between population samples in the three French MONICA nutritional surveys. Rev. Epidemiol. Sante Publique. 38:1990;517-523.
74. Khachik F., Beecher G.R., Goli M.B., Lusby W.R. Separation and quantitation of carotenoids in foods. Methods Enzymol. 213:1992a;347-359.
75. Khachik F., Beecher G.R., Goli M.B., Lusby W.R., Daitch C.E. Separation and quantification of carotenoids in human plasma. Methods Enzymol. 213:1992b;205-219.
76. Khachik F., Beecher G.R., Smith J.C. Jr. Lutein, lycopene, and their oxidative metabolites in chemoprevention of cancer. J. Cell Biochem. Suppl. 22:1995a;236-246.
77. Khachik F., Bernstein P.S., Garland D.L. Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest. Ophthalmol. Vis. Sci. 38:1997a;1802-1811.
78. Khachik F., de Moura F.F., Than D.Y., Aebischer C.P., Bernstein P.S. Transformations of selected carotenoids in plasma, liver, and ocular tissues of humans and in nonprimate animal models. Invest. Ophthalmol. Vis. Sci. 43:2002;3383-3392.
79. Khachik, F., Nir, Z., Ausich, R.L., Stock, K., Pfander, H., 1995b. Distribution of carotenoids in fruits and vegetables as a criterion for the selection of appropriate chemopreventive agents. In: Proceedings of the International Conference on Food Factors - Chemistry and Cancer Prevention. pp. 204-208.
80. Khachik F., Spangler C.J., Smith J.C. Identification, quantification, and relative concentrations of carotenoids and their metabolites in human milk and serum. Anal. Chem. 69:1997b;1873-1881.
81. Klein B.E., Klein R., Linton K.L. Prevalence of age-related lens opacities in a population. The Beaver Dam Eye Study. Ophthalmology. 99:1992;546-552.
82. Kostic D., White W.S., Olson J.A. Intestinal absorption, serum clearance, and interactions between lutein and beta-carotene when administered to human adults in separate or combined oral doses. Am. J. Clin. Nutr. 62:1995;604-610.
83. Krieglstein C.F., Granger D.N. Adhesion molecules and their role in vascular disease. Am. J. Hypertens. 14:2001;44S-54S.
84. Krinsky N.I. Antioxidant functions of carotenoids. Free Radic. Biol. Med. 7:1989;617-635.
85. Krinsky N.I. Possible biologic mechanisms for a protective role of xanthophylls. J. Nutr. 132:2002;540S-542S.
86. Kritchevsky S.B., Bush A.J., Pahor M., Gross M.D. Serum carotenoids and markers of inflammation in nonsmokers. Am. J. Epidemiol. 152:2000;1065-1071.
87. Kruger C.L., Murphy M., DeFreitas Z., Pfannkuch F., Heimbach J. An innovative approach to the determination of safety for a dietary ingredient derived from a new source: case study using a crystalline lutein product. Food Chem. Toxicol. 40:2002;1535-1549.
88. Landrum J.T. Serum and macular pigment response to 2.4 mg dosage of lutein (Abstract). Assoc. Res. Vision Ophthalmol. 41:2000;S60.
89. Landrum J.T., Bone R.A. Lutein, zeaxanthin, and the macular pigment. Arch. Biochem. Biophys. 385:2001;28-40.
90. Landrum J.T., Bone R.A., Jos H., Kilburn M.D., Moore L.L., Sprague K.E. A 1 year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp. Eye Res. 65:1997;57-62.
91. Le Marchand L., Harkin J.H., Bach F., Kolonel L.N., Wilkens L.R., Stacewicz-Sapuntzakis M., Bowen P.E., Beecher G.R., Laudon F., Baque P.et al. An ecological study of diet and lung cancer in the South Pacific. Int. J. Cancer. 63:1995;18-23.
92. Le Marchand L., Hankin J.H., Kolonel L.N., Beecher G.R., Wilkens L.R., Zhao L.P. Intake of specific carotenoids and lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 2:1993;183-187.
93. Lyle B.J., Mares-Perlman J.A., Klein B.E., Klein I.L., Greger J.L. Antioxidant intake and risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study. Am. J. Epidemiol. 149:1999a;801-809.
94. Lyle B.J., Mares-Perlman J.A., Klein B.E., Klein R., Palta M., Bowen P.E., Greger J.L. Serum carotenoids and tocopherols and incidence of age-related nuclear cataract. Am. J. Clin. Nutr. 69:1999b;272-277.
95. Malinow M.R., Feeney-Burns L., Peterson L.H., Klein M.L., Neuringer M. Diet-related macular anomalies in monkeys. Invest. Ophthalmol. Vis. Sci. 19:1980;857-863.
96. Mares-Perlman J.A., Brady W.E., Klein R., Klein B.E., Bowen P., Stacewicz-Sapuntzakis M., Palta M. Serum antioxidants and age-related macular degeneration in a population-based case-control study. Arch. Ophthalmol. 113:1995;1518-1523.
97. Mares-Perlman J.A., Fisher A.I., Palta M., Block G., Millen A.E., Wright J.D. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey. Am. J. Epidemiol. 153:2001;424-432.
98. Mares-Perlman J.A., Millen A.E., Ficek T.L., Hankinson S.E. The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease. Overview J. Nutr. 132:2002;518S-524S.
99. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113:1983;173-215.
100. Martin K.R., Wu D., Meydani M. The effect of carotenoids on the expression of cell surface adhesion molecules and binding of monocytes to human aortic endothelial cells. Atherosclerosis. 150:2000;265-274.
101. Massacesi A.L., Faletra R., Gerosa F., Staurenghi G., Orzalesi N. The effect of oral supplementation of macular carotenoids (lutein and zeaxanthin) on the prevention of age-related macular degeneration: a 18 months of follow up study. Assoc. Res. Vision Ophthalmol. 42:2001;S234.
102. McClean R., McCrum E., Scally G., McMaster D., Patterson C., Jackson N., Evans A. Dietary patterns in the Belfast MONICA Project. Proc. Nutr. Soc. 49:1990;297-305.
103. McEligot A.J., Rock C.L., Shanks T.G., Flatt S.W., Newman V., Faerber S., Pierce J.P. Comparison of serum carotenoid responses between women consuming vegetable juice and women consuming raw or cooked vegetables. Cancer Epidemiol. Biomarkers Prev. 8:1999;227-231.
104. Michaud D.S., Feskanich D., Rimm E.B., Colditz G.A., Speizer F.E., Willett W.C., Giovannucci E. Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts. Am. J. Clin. Nutr. 72:2000;900-997.
105. Micozzi M.S., Brown E.D., Edwards B.K., Bieri J.G., Taylor P.R., Khachik F., Beecher G.R., Smith J.C. Jr. Plasma carotenoid response to chronic intake of selected foods and beta-carotene supplements in men. Am. J. Clin. Nutr. 55:1992;1120-1125.
106. Moeller S.M., Jacques P.F., Blumberg J.B. The potential role of dietary xanthophylls in cataract and age-related macular degeneration. J. Am. Coll. Nutr. 19:2000;522S-527S.
107. Molecular Aspects of Medicine, 2002. vol. 23. p. 41.
108. National Institute of Medicine, 2001. DRI's for Vit A, Vit As, B, Cr, Cu, I, Fe, Mn, Mo, Ni, Si, V, and Zn. National Academy Press, National Institute of Medicine, Washington, DC.
109. Nebeling L.C., Forman M.R., Graubard B.I., Snyder R.A. Changes in carotenoid intake in the United States: the 1987 and 1992 National Health Interview Surveys. J. Am. Diet. Assoc. 97:1997;991-996.
110. Neuringer M., Johnson E.J., Snodderly D.M., Sandstrom M.M., Schalch W.M. Supplementation of carotenoid-depleted rhesus monkeys with lutein or zeaxanthin: effects on serum and adipose tissue carotenoids and macular pigment. Assoc. Res. Vision Ophthalmol. 42:2001;S224.
111. Newcomb P.A., Klein R., Massoth K.M. Education to increase ophthalmologic care in older onset diabetes patients:indications from the Wisconsin Epidemiologic Study of Diabetic Retinopathy. J. Diabetes Complications. 6:1992;211-217.
112. Niles R.M. The use of retinoids in the prevention and treatment of skin cancer. Expert Opin. Pharmacother. 3:2002;299-303.
113. Noy, N., 2000. Vitamin A. In: Stipanuk, M.H. (Ed.), Biochemical and Physiological Aspects of Human Nutrition. W.B. Saunders Company, Philadelphia, PA, pp. 599-618.
114. Okai, Y., Higashi-Okai, K., Yano, Y., Otani, S., 1996. Identification of antimutagenic substances in an extract of edible red alga, Porphyra tenera (Asakusa-nori) [published erratum appears in 1996 in Cancer Lett. 103 (2), 241]. Cancer Lett. 100, 235-240.
115. Olmedilla B., Granado F., Blanco I., Vaquero M. Lutein, but not alpha-tocopherol, supplementation improves visual function in patients with age-related cataracts: a 2-year double-blind, placebo-controlled pilot study. Nutrition. 19:2003;21-24.
116. Olmedilla B., Orarado F., Gil-Martinez E., Blanco I. Supplementation with lutein (4 months) and alpha-tocopherol (2 months), in separate or combined oral doses, in control men. Cancer Lett. 114:1997;179-181.
117. Olmedilla B., Granado F., Southon S., Wright A.J., Blanco I., Gil-Martinez E., Van Den Berg H., Corridan B., Roussel A.M., Chopra M., Thurnham D.I. Serum concentrations of carotenoids and Vitamins A, E, and C in control subjects from five European countries. Br. J. Nutr. 85:2001;227-238.
118. Olmedilla B., Granado F., Southon S., Wright A.J., Blanco I., Gil-Martinez E., van den Berg H., Thurnham D., Corridan B., Chopra M., Hininger I. A European multicentre, placebo-controlled supplementation study with alpha-tocopherol, carotene-rich palm oil, lutein or lycopene: analysis of serum responses. Clin. Sci.(Lond.). 102:2002;447-456.
119. Olson J.A., Krinsky N.I. Introduction: the colorful, fascinating world of the carotenoids - important physiologic modulators. FASEB J. 9:1995;1547-1550.
120. Omenn G.S., Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Glass A., Keogh J.P., Meyskens F.L., Valanis B., Williams J.H., Barnhart S., Hammar S. Effects of a combination of beta carotene and Vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 334:1996;1150-1155.
121. O'Neill M.E., Carroll Y., Corridan B., Olmedilla B., Granado F., Blanco I., Van den Berg H., Hininger I., Rousell A.M., Chopra M., Southon S., Thurnham D.I. A European carotenoid database to assess carotenoid intakes and its use in a five country comparative study. Br. J. Nutr. 85:2001;499-507.
122. O'Neill M.E., Thurnham D.I. Intestinal absorption of beta-carotene, lycopene and lutein in men and women following a standard meal: response curves in the triacylglycerol-rich lipoprotein fraction [see comments]. Br. J. Nutr. 79:1998;149-159.
123. Palozza P. Prooxidant actions of carotenoids in biologic systems. Nutr. Rev. 56:1998;257-265.
124. Patrick L. Beta-carotene: the controversy continues. Altern. Med. Rev. 5:2000;530-545.
125. Peng Y.M., Peng Y.S., Lin Y., Moon T., Roe D.J., Ritenbaug C. Concentrations and plasma-tissue-diet relationships of carotenoids, retinoids, and tocopherols in humans. Nutr. Cancer. 23:1995;233-246.
126. Phelan J.K., Bok D. A brief review of retinitis pigmentosa and the identified retinitis pigmentosa genes. Mol. Vis. 6:2000;116-124.
127. Pryor W.A., Stahl W., Rock C.L. Beta carotene: from biochemistry to clinical trials. Nutr. Rev. 58:2000;39-53.
128. Rauscher R., Edenharder R., Platt K.L. In vitro antimutagenic and in vivo anticlastogenic effects of carotenoids and solvent extracts from fruits and vegetables rich in carotenoids. Mutat. Res. 413:1998;129-142.
129. Ribaya-Mercado J.D., Garmyn M., Gilchrest B.A., Russell R.M. Skin lycopene is destroyed preferentially over beta-carotene during ultraviolet irradiation in humans. J. Nutr. 125:1995;1854-1859.
130. Richer S. ARMD - pilot (case series) environmental intervention data. J. Am. Optom. Assoc. 70:1999a;24-36.
131. Richer S. A protocol for the evaluation and treatment of atrophic age-related macular degeneration. J. Am. Optom. Assoc. 70:1999b;13-23.
132. Richer, S., Stiles, W., Statkute, L., Pei, K.Y., Frankowski, J., Nyland, J., Pulido, J., Rudy, D., 2002. The lutein antioxidant supplementation trial (LAST). In: Proceedings of the Association for Research in Vision and Ophthalmology. Ft. Lauderdale, FL, p. B539.
133. Roodenburg A.J., Leenen R., van het Hof K.H., Weststrate J.A., Tijburg L.B. Amount of fat in the diet affects bioavailability of lutein esters but not of alpha-carotene, beta-carotene, and Vitamin E in humans (see comments). Am. J. Clin. Nutr. 71:2000;1187-1193.
134. Russell R.M. The Vitamin A spectrum: from deficiency to toxicity. Am. J. Clin. Nutr. 71:2000;878-884.
135. Schmitz H.H., Poor C.L., Gugger E.T., Erdman J.W. Jr. Analysis of carotenoids in human and animal tissues. Methods Enzymol. 214:1993;102-116.
136. Seddon J.M., Ajani U.A., Sperduto F.L.D., Hiller R., Blair N., Burton T.C., Farber M.D., Gragoudas E.S., Haller J., Miller D.T.et al. Dietary carotenoids, Vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. Jam. 272:1994;1413-1420.
137. Snodderly D.M. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am. J. Clin. Nutr. 62:1995;1448S-1461S.
138. Snodderly D.M., Handelman G.J., Adler A.J. Distribution of individual macular pigment carotenoids in central retina of mascaque and squirrel monkeys. Invest. Ophthalmol. Via Sci. 32:1991;268-279.
139. Sommerburg O., Keunen J.E., Bird A.C., van Kuijk F.J. Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br. J. Ophthalmol. 82:1998;907-910.
140. Sorg O., Tran C., Carraux P., Didierjean L., Falson F., Saurat J.H. Oxidative stress-independent depletion of epidermal Vitamin A by UVA. J. Invest. Dermatol. 118:2002;513-518.
141. Stahl W., Heinrich U., Jungmann H., Sies H., Tronnier H. Carotenoids and carotenoids plus Vitamin E protect against ultraviolet light-induced erythema in humans. Am. J. Clin. Nutr. 71:2000;795-798.
142. Stahl W., Sies H. Canotenoids and protection against solar UV radiation. Skin Pharmacol. Appl. Skin Physiol. 15:2002;291-296.
143. Stark, C., 2000. Translating biochemical and physiological requirements into practice. In: Stipanuk, M.H. (Ed.), Biochemical and Physiological Aspects of Human Nutrition. W. B. Saunders Company, Philedelphia, PA, pp. 945-959.
144. Steinberg E.P., Javitt J.C., Sharkey P.D., Zuckerman A., Legro M.W., Anderson G.F., Bass E.B., O'Day D. The content and cost of cataract surgery. Arch. Ophthalmol. 111:1993;1041-1049.
145. Su Q., Rowley K.G., Itsiopoulos C., O'Dea K. Identification and quantitation of major carotenoids in selected components of the Mediterranean diet: green leafy vegetables, figs and olive oil. Eur. J. Clin. Nutr. 56:2002;1149-1154.
146. Sundelin S.P., Nilsson S.E. Lipofuscin-formation in retinal pigment epithelial cells is reduced by antioxidants. Free Radic. Biol. Med. 31:2001;217-225.
147. Taylor C.R., Stern R.S., Leyden J.J., Gilchrest B.A. Photoaging/ photodamage and photoprotection. J. Am. Acad. Dermatol. 22:1990;1-15.
148. Taylor E.J., Evans F.J. Anti-psoriatic action of lutein demonstrated by inhibition of rat photodermatitis. J. Pharm. Pharmacol. 50:1998;78.
149. The National Academy of Sciences, 2000. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. National Academy Press, Washington, DC.
150. Tyssandier V., Cardinault N., Caris-Veyrat C., Amiot M.J., Grolier P., Bouteloup C., Azais-Braesco V., Borel P. Vegetable-borne lutein, lycopene, and betacarotene compete for incorporation into chylomicrons, with no adverse effect on the medium-term (3-week) plasma status of carotenoids in humans. Am. J. Clin. Nutr. 75:2002;526-534.
151. U.S. Department of Agriculture, A.R.S., 1998. USDA-NCC Carotenoid Database for US Foods - 1998.
152. U.S. Department of Agriculture, A.R.S., 2000. Continuing Survey of Food Intakes by Individuals, Data and Documentation 1994-1996, 1998.
153. U.S. Department of Agriculture, H.N.I.S., 1996. The food Guide Pyramid.
154. U.S. Department of Health and Human Services, N.C.F.H.S., 1999. Third National Health and Examination Survey (NHANES III), 1988-1994.
155. van den Berg H. Effect of lutein on beta-carotene absorption and cleavage. Ins. J. Vitam. Nutr. Res. 68:1998;360-365.
156. van den Berg H. Carotenoid interactions. Nutr. Rev. 57:1999;1-10.
157. van het Hof K.H., Brouwer I.A., West C.E., Haddeman E., Steegers-Theunissen R.P., van Dusseldorp M., Weststrate J.A., Eskes T.K., Hautvast J.G. Bioavailability of lutein from vegetables is 5 times higher than that of beta-carotene. Am. J. Clin. Nutr. 70:1999a;261-268.
158. van het Hof K.H., Tijburg L.B., Pietrzik K., Weststrate J.A. Influence of feeding different vegetables on plasma levels of carotenoids, folate and Vitamin C. Effect of disruption of the vegetable matrix. Br. J. Nutr. 82:1999b;203-212.
159. van het Hof K.H., West C.E., Weststrate J.A., Hautvast J.G. Dietary factors that affect the bioavailability of carotenoids. J. Nutr. 130:2000;503-506.
160. van Vliet T. Absorption of beta-carotene and other carotenoids in humans and animal models. Eur. J. Clin. Nutr. 50(Suppl. 3):1996;S32-S37.
161. Wang X.D., Liu C., Bronson R.T., Smith D.E., Krinsky N.I., Russell M. Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. J. Natl. Cancer Inst. 91:1999;60-66.
162. White W.S., Kim C.I., Kalkwarf H.J., Bustos P., Roe D.A. Ultraviolet light-induced reductions in plasma carotenoid levels. Am. J. Clin Nutr. 47:1988;879-883.
163. Williams A.W., Boileau T.W., Erdman J.W. Factors influencing the uptake and absorption of carotenoids. Proc. Soc. Exp. Biol. Med. 218:1998;106-108.
164. Wingerath T., Sies H., Stahl W. Xanthophyll esters in human skin. Arch. Biochem. Biophys. 355:1998;271-274.
165. Winkler B.S., Boulton M.E., Gottsch J.D., Sternberg P. Oxidative damage and age-related macular degeneration. Mol. Vis. 5:1999;32.
166. Wolf G. The effect of low and high doses of beta-carotene and exposure to cigarette smoke on the lungs of ferrets. Nutr. Rev. 60:2002;88-90.
167. Wrona M., Rozanowska M., Czub-Pelech B., Sarna T. Antioxidant action of zeaxanthin in protection of human RPE cells against oxidative damage. Assoc. Res. Vision Ophthalmol. 42:2001;S576.
168. Wu, A., Patnak, M.A., Sifakis, M., Goukassian, D.A., Gonzalez, S., 2002. Oral administration of lutein modulates cell proliferation induced by acute UVB radiation in the SKh-1 hairless mouse animal model (Abstract). In: Proceedings of the Society for Investigative Dermatology. Los Angeles, CA.
169. Yao L., Liang Y., Trahanovsky W.S., Serfass R.E., White W.S. Use of a 13C tracer to quantify the plasma appearance of a physiological dose of lutein in humans. Lipids. 35:2000;339-348.
170. Yemelyanov A.Y., Katz N.B., Bernstein P.S. Ligand-binding characterization of xanthophyll carotenoids to solubilized membrane proteins derived from human retina. Exp. Eye Res. 72:2001;381-392.
171. Yeum K.J., Russell R.M. Carotenoid bioavailability and bioconversion. Annu. Rev. Nutr. 22:2002;483-504.
172. Yeum K.J., Shang F.M., Schalch W.M., Russell R.M., Taylor K. Fat-soluble nutrient concentrations in different layers of human cataractous lens. Curr. Eye Res. 19:1999;502-505.
173. Yeum K.J., Taylor A., Tang G., Russell R.M. Measurement of carotenoids, retinoids, and tocopherols in human lenses. Invest. Ophthalmol. Vis. Sci. 36:1995;2756-2761.